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INTRODUCTION AND OBJECTIVES: 
Approximately half of all Ph-like B cell acute 
lymphoblastic leukemia is characterized by 
overexpression of CRLF2 (CRLF2 B-ALL). 
CRLF2 B-ALL is associated with high rates 
of relapse and is more prevalent in Hispanic 
children with Native American ancestry. 
CRLF2, together with the IL-7 receptor alpha 
(IL-7Ra), comprises a receptor complex that 
is activated by the cytokine, TSLP. Receptor 
activation by TSLP induces JAK2/STAT5 
and PI3/AKT/mTOR signals that promote 
survival and proliferation of leukemia cells. 
To study the role of TSLP in CRLF2 B-ALL, 
we developed a patient-derived xenograft 
(PDX) model of CRLF2 B-ALL that allows 
us to vary circulating levels of human TSLP 
(hTSLP) in a physiologic environment. We 
generated PDX from patients’ CRLF2 B-
ALL cells and compared leukemia burden in 
mice with varying levels of hTSLP. CRLF2 
B-ALL cells grew robustly in PDX models 
with hTSLP levels at or below levels present 
in pediatric cancer patients (~10 pg/mL). In 
contrast, CRLF2 B-ALL cells were 
essentially eliminated in PDXs with hTSLP 
at high physiological levels (40-140 pg/mL). 
These data suggest that high physiologic 
levels of TSLP exert a potent anti-leukemia 
effect in Ph-like B-ALL with overexpression 
CRLF2. 
The objective of the proposed research was to 
evaluate potential mechanisms of TSLP’s 
anti-leukemia effects. 
 
METHODS: TSLP dose response studies 
were performed and flow cytometry was used 
to evaluate the effect of TSLP on CRLF2 
signaling, surface expression of TSLP 
receptor components (IL-7Ra and CRLF2) 
and expression of the Suppressor of Cytokine 
Signaling (SOCS) proteins in CRLF2 B-ALL 
cell lines (MUTZ5 and CALL-4) and CRLF2 
B-ALL cells from Hispanic pediatric 
patients. Whole genome microarray was used 
to evaluate TSLP effects on SOCS gene 
expression in patient samples. 
 
RESULTS: CRLF2 B-ALL cell lines 
cultured with TSLP showed a dose-
dependent loss in the ability to induce 
phosphorylation of STAT5 and S6 
(downstream of PI3/AKT/mTOR) following 
TSLP stimulation. This loss was correlated 
with a complete loss of surface IL-7Ra, and 
maintained for 24-48 hours following a pulse 
of high-dose, but not low-dose, hTSLP. The 
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loss of surface CRLF2 was minimal. The loss 
of signaling and surface IL-7Ra could be 
prolonged if high-dose hTSLP levels were 
maintained. Similarly, preliminary studies of 
CRLF2 B-ALL cells from pediatric patients 
showed a loss of CRLF2 signaling and 
surface IL-7Ra following culture with high-
dose TSLP. A potential mechanism for the 
effects of high-dose TSLP are the suppressor 
of cytokine signaling (SOCS) genes. These 
genes encode a family of proteins (SOCS1-7 
and CISH) that regulate cytokine signaling 
via negative feedback through multiple 
mechanisms including ubiquitin-mediated 
cytokine receptor degradation. 
Whole genome microarray showed that 
SOCS1, SOCS2, SOCS3 and CISH mRNA 
are upregulated in patient CRLF2 B-ALL 
cells cultured with high-dose TSLP. Flow 
cytometry analysis showed that high-dose 
TSLP upregulates SOCS1 and SOCS3 
proteins in CRLF2 B-ALL cell lines and in 
patient samples. 
 
CONCLUSIONS: These data provide 
evidence that TSLP exerts anti-leukemia 
effects by shutting down CRLF2-mediated 
signals and that these effects are at least 
partially mediated by the loss of the IL-7Ra 
component, and potentially through SOCS 
family proteins. These studies identify the 
human TSLP cytokine as a potential biologic 
therapy to treat CRLF2 B-ALL. 
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